sim0505
·Code: SIM0505, SCR-9359
sim0505: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| NextCure, Inc. (NXTC) | Phase 1 |
Clinical Trials (1)
A Phase I First-in-human, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants With Advanced Solid Tumors
Frequently asked questions
Who is developing sim0505?
sim0505 is being developed by NextCure, Inc..
How many clinical trials involve sim0505?
BioSniper tracks 1 clinical trial involving sim0505.
Get deeper analysis on sim0505
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis